Biden taps Vanderbilt’s Kimryn Rathmell to succeed Bertagnolli as the NIH’s cancer chiefnews2023-11-17T17:57:26+00:00November 17th, 2023|Endpoints News|
Merck notches 38th approval for Keytruda, seventh indication for gastrointestinal cancernews2023-11-17T17:21:07+00:00November 17th, 2023|Endpoints News|
Astellas details potential reason behind deaths in rare disease gene therapy trialnews2023-11-17T16:20:33+00:00November 17th, 2023|Endpoints News|
CDMOs investigate how to support GLP-1 manufacturing, pharma considers supply chain diversity: #Jefferies23news2023-11-17T16:08:23+00:00November 17th, 2023|Endpoints News|
Danaher/Abcam deal set to close next month; Cereno’s loan; March Biosciences to advance its CAR-T into PhIInews2023-11-17T15:48:25+00:00November 17th, 2023|Endpoints News|
Lilly invests $2.5B in new German site to boost tirzepatide supply, $100M for local biotechsnews2023-11-17T15:29:12+00:00November 17th, 2023|Endpoints News|
Why a pair of health tech startups just merged their referral and specialty care businessesnews2023-11-17T14:39:00+00:00November 17th, 2023|Endpoints News|
AstraZeneca subsidiary to sell its Bangalore site, to hunt for external manufacturer news2023-11-17T12:20:58+00:00November 17th, 2023|Endpoints News|
FDA approves AstraZeneca’s AKT inhibitor Truqap for subtype of breast cancernews2023-11-17T11:57:35+00:00November 17th, 2023|Endpoints News|
Oncolytic virus experts discuss biggest lessons from past failuresnews2023-11-17T11:26:47+00:00November 17th, 2023|Endpoints News|
